Topics

bluebird bio Announces Investor Events in May

08:00 EDT 3 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Company will host an Analyst Day, Thursday, May 9, at 8:30 am ET at The Maxwell Hotel NYC, New York, NY. In addition, members of the management team will...

Other Sources for this Article

Investors:
Elizabeth Pingpank, (617) 914-8736
epingpank@bluebirdbio.com
or
Media:
Jenn Snyder, (617) 448-0281
JSnyder@bluebirdbio.com

NEXT ARTICLE

More From BioPortfolio on "bluebird bio Announces Investor Events in May"

Quick Search

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...